Remove topic neuroscience
article thumbnail

Psychedelic drugs may launch a new era in psychiatric treatment, brain scientists say

NPR Health - Shots

Psychedelic drugs were a hot topic at this year's Society for Neuroscience meeting. Researchers hope the drugs can help people with disorders like depression and PTSD. Image credit: Jahi Chikwendiu/The Washington Post via Getty Images)

Scientist 131
article thumbnail

Capsida Biotherapeutics and Prevail to develop CNS gene therapies

Pharmaceutical Technology

Capsida Biotherapeutics CEO Peter Anastasiou said: “Prevail’s expertise in neuroscience, gene therapy R&D, and access to Lilly’s world-class commercialization capabilities complements Capsida’s fully integrated approach, including our next-generation AAV engineering platform. Free Whitepaper.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Welcome to 1st Rare & Genetic Neurodegenerative Drug Development Summit

pharmaphorum

Neuroscience is arguably the next great frontier in medicine and 2022 dawned with a wave of exhilarating progress for the neurodegenerative drug development community. The company will also use funds to advance work on preclinical therapies, including one for amyotrophic lateral sclerosis (ALS).

article thumbnail

FDA advisory committee meeting delays approval of donanemab

Drug Discovery World

The FDA has said it hopes to further understand topics related to evaluating the safety and efficacy of donanemab, including the safety results in donanemab-treated patients and the efficacy implications of the unique trial design of the TRAILBLAZER-ALZ 2 study.

Trials 52
article thumbnail

DDW Fall 2022 issue with exclusive ELRIG Drug Discovery 2022 supplement? 

Drug Discovery World

Specialty Spotlight on Neuroscience,? You can register here and topics will include: . The Fall Issue of the Drug Discovery World Magazine is out now. . the magazine?is is available to download and read for free on the DDW App.? . Changes in the laboratory workplace incorporating automation.

Drugs 52
article thumbnail

5 Top Clinical Research Themes and Trends of 2023 (and 2024)

VirTrial

As the global leaders in CNS research optimization for over 20 years with proven endpoint quality solutions supported by renowned leaders in dementia, schizophrenia, Parkinson’s research and more, Signant is well-positioned to continue helping sponsors tackle the toughest challenges in neuroscience.

article thumbnail

Expanding ketamine’s horizons to treat rare neurological disorders

Pharmaceutical Technology

Earlier this month, New Jersey-based Silo Pharma announced the start of an IND-enabling study of a topical ketamine formulation for fibromyalgia, a chronic condition that causes pain and fatigue. In 1970, the FDA approved ketamine as an anesthetic.

Research 275